Home › Funds › BROGAN FINANCIAL, INC. › ABT

BROGAN FINANCIAL, INC. position in ABT

ABBOTT LABORATORIES · Health Care

BROGAN FINANCIAL, INC. reported holding 3,186 shares of ABT (ABBOTT LABORATORIES) in its Q3 2026 13F filing — a position valued at US$315K, representing 0.11% of its reported portfolio and ranking #44 among its reported holdings. BROGAN FINANCIAL, INC. has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)3.19K sh
Reported value held$314.92K
Portfolio Weight0.11%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How BROGAN FINANCIAL, INC.'s ABT position evolved

BROGAN FINANCIAL, INC. first disclosed a stake in ABT in Q3 2023 at 3,928 shares (US$380K). The position peaked in Q4 2023 at 3,948 shares, worth US$435K. Across 13 filings, BROGAN FINANCIAL, INC. increased the stake 5 time(s), trimmed it 4 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 3,186 shares valued at US$315K — a reduction of -53 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 3.93K $380.44K New
Q4 2023 3.95K $434.59K Add
Q1 2024 3.02K $343.27K Reduce
Q2 2024 3.04K $315.43K Add
Q3 2024 2.99K $340.98K Reduce
Q4 2024 3.00K $338.99K Hold
Q1 2025 3.21K $426.49K Add
Q2 2025 3.02K $411.23K Reduce
Q3 2025 3.04K $406.79K Hold
Q4 2025 3.05K $382.19K Hold
Q1 2026 3.07K $314.83K Add
Q2 2026 3.24K $293.90K Add
Q3 2026 3.19K $314.92K Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 21 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has BROGAN FINANCIAL, INC. held ABT?

BROGAN FINANCIAL, INC. has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is BROGAN FINANCIAL, INC.'s current position in ABT?

As of Q3 2026, BROGAN FINANCIAL, INC. holds 3.19K shares of ABT (ABBOTT LABORATORIES), valued at $314.92K, representing 0.11% of its reported portfolio and ranking #44.

Has BROGAN FINANCIAL, INC. been buying or selling ABT?

In the latest 13F filing (Q3 2026), BROGAN FINANCIAL, INC. reduced its position in ABT. The position peaked in Q4 2023 at 3.95K shares.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 21 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.